IO Biotech (IOBT) Income Statement (2020 - 2025)
Income Statement report data from Sep 30, 2020 to Sep 30, 2025 for IO Biotech (IOBT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||
Total Revenue | - | - | 410K | - | 1.07M (-18.32%) | 1.31M (-19.14%) | 1.62M (-16.92%) | 1.95M (+14.04%) | 1.71M (+42.50%) | 1.20M (+16.50%) | 1.03M (+32.05%) | 780K (+69.57%) | 460K (+187.50%) | 160K (+700.00%) | 20K | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||
Research And Development | 14M (-17.48%) | 17M (+1.65%) | 16M | - | 20M (+27.32%) | 16M (+10.76%) | 14M (-34.27%) | 22M (+23.27%) | 18M (+7.03%) | 17M (+38.66%) | 12M (-17.53%) | 14M (+44.01%) | 10M (-18.07%) | 12M (+18.62%) | 10M (-37.29%) | 16M (+298.06%) | 4.13M (-38.72%) | 6.74M (+136.49%) | 2.85M (+2.52%) | 2.78M |
Selling General And Administrative | 5.61M (-13.96%) | 6.52M (+4.99%) | 6.21M | - | 6.33M (+11.25%) | 5.69M (-3.40%) | 5.89M (-8.11%) | 6.41M (+9.95%) | 5.83M (+8.97%) | 5.35M (-11.13%) | 6.02M (+1.01%) | 5.96M (+2.05%) | 5.84M (-1.68%) | 5.94M (-11.34%) | 6.70M (+35.08%) | 4.96M (+70.45%) | 2.91M (+29.33%) | 2.25M (+131.96%) | 970K (+49.23%) | 650K |
Operating Expenses | 19M (-16.44%) | 23M (+2.61%) | 23M | - | 27M (+23.08%) | 22M (+6.58%) | 20M (-28.32%) | 28M (+20.02%) | 23M (+7.46%) | 22M (+21.93%) | 18M (-12.11%) | 20M (+28.48%) | 16M (-12.61%) | 18M (+6.76%) | 17M (-20.51%) | 21M (+203.98%) | 7.04M (-21.60%) | 8.98M (+135.70%) | 3.81M (+11.08%) | 3.43M |
Depreciation And Amortization | 100K (0.00%) | 100K (0.00%) | 100K | - | 100K (0.00%) | 100K (0.00%) | 100K | -50.00K | 100K (0.00%) | 100K (+100.00%) | 50K (-44.44%) | 90K (+800.00%) | 10K | - | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -19.35M (-16.49%) | -23.17M (+2.61%) | -22.58M | - | -26.50M (+23.08%) | -21.53M (+6.58%) | -20.20M (-28.32%) | -28.18M (+20.02%) | -23.48M (+7.46%) | -21.85M (+21.93%) | -17.92M (-12.11%) | -20.39M (+28.56%) | -15.86M (-12.67%) | -18.16M (+6.76%) | -17.01M (-20.51%) | -21.40M (+203.98%) | -7.04M (-21.60%) | -8.98M (+135.70%) | -3.81M (+11.08%) | -3.43M |
Ebit | -19.35M (-16.49%) | -23.17M (+2.61%) | -22.58M (-76.36%) | -95.50M (+260.38%) | -26.50M (+23.08%) | -21.53M (+6.58%) | -20.20M (-28.32%) | -28.18M (+20.02%) | -23.48M (+7.46%) | -21.85M (+21.93%) | -17.92M (-12.11%) | -20.39M (+28.56%) | -15.86M (-12.67%) | -18.16M (+6.76%) | -17.01M (-20.51%) | -21.40M (+203.98%) | -7.04M (-21.60%) | -8.98M (+135.70%) | -3.81M (+11.08%) | -3.43M |
EBITDA | -19.25M (-16.56%) | -23.07M (+2.62%) | -22.48M (-76.46%) | -95.50M (+261.74%) | -26.40M (+23.19%) | -21.43M (+6.62%) | -20.10M (-28.80%) | -28.23M (+20.74%) | -23.38M (+7.49%) | -21.75M (+21.71%) | -17.87M (-11.97%) | -20.30M (+28.08%) | -15.85M (-12.72%) | -18.16M (+6.76%) | -17.01M | 5.13M | -4.39M (-88.53%) | -38.29M (+940.49%) | -3.68M (+5.75%) | -3.48M |
Other Income / Expenses | ||||||||||||||||||||
Interest Income | 260K (-7.14%) | 280K | - | - | 1.07M (-18.32%) | 1.31M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 80K (-20.00%) | 100K (-16.67%) | 120K (-20.00%) | 150K (+114.29%) | 70K (0.00%) | 70K (0.00%) | 70K (+600.00%) | 10K |
Net Interest Income | 260K (-7.14%) | 280K | - | - | 1.07M (-18.32%) | 1.31M | - | - | - | - | - | - | -80.00K (-20.00%) | -100.00K (-16.67%) | -120.00K (-20.00%) | -150.00K (+114.29%) | -70.00K (0.00%) | -70.00K (0.00%) | -70.00K (+600.00%) | -10.00K |
Other Non Operating Income | 9.31M | -2.93M | 310K | - | 2.70M (+121.31%) | 1.22M (+5.17%) | 1.16M (-81.32%) | 6.21M (+353.28%) | 1.37M (+13.22%) | 1.21M (-6.20%) | 1.29M (+4.03%) | 1.24M (+327.59%) | 290K | -230.00K (+76.92%) | -130.00K (-99.51%) | -26.58M | 2.58M | -29.38M | 70K | -60.00K |
Net Income | ||||||||||||||||||||
Income Before Tax | -10.04M (-61.53%) | -26.10M (+17.20%) | -22.27M | - | -23.81M (+17.23%) | -20.31M (+6.67%) | -19.04M (-26.29%) | -25.83M (+16.77%) | -22.12M (+7.12%) | -20.65M (+24.10%) | -16.64M (-12.79%) | -19.08M (+22.54%) | -15.57M (-15.33%) | -18.39M (+7.29%) | -17.14M (-19.30%) | -21.24M (+376.23%) | -4.46M (-88.37%) | -38.36M (+922.93%) | -3.75M | - |
Income Tax Expense | -1.66M | 120K (-20.00%) | 150K | - | 210K (-43.24%) | 370K (-11.90%) | 420K (+20.00%) | 350K | -440.00K | 530K (+29.27%) | 410K (-58.59%) | 990K (+725.00%) | 120K (+20.00%) | 100K (+42.86%) | 70K (0.00%) | 70K | - | - | - | - |
Net Income From Continuing Operations | -8.38M (-68.04%) | -26.22M (+16.95%) | -22.42M (-76.52%) | -95.50M (+297.75%) | -24.01M (+16.05%) | -20.69M (+6.32%) | -19.46M (-25.67%) | -26.18M (+20.76%) | -21.68M (+2.36%) | -21.18M (+24.30%) | -17.04M (-15.10%) | -20.07M (+27.92%) | -15.69M (-15.14%) | -18.49M (+7.50%) | -17.20M (-19.29%) | -21.31M (+377.80%) | -4.46M (-88.37%) | -38.36M (+922.93%) | -3.75M (+7.45%) | -3.49M |
Net Income | -8.38M (-68.04%) | -26.22M (+16.95%) | -22.42M (-76.52%) | -95.50M (+297.75%) | -24.01M (+16.05%) | -20.69M (+6.32%) | -19.46M (-25.67%) | -26.18M (+20.76%) | -21.68M (+2.36%) | -21.18M (+24.30%) | -17.04M (-15.10%) | -20.07M (+27.92%) | -15.69M (-15.14%) | -18.49M (+7.50%) | -17.20M (-19.29%) | -21.31M (+377.80%) | -4.46M (-88.37%) | -38.36M (+922.93%) | -3.75M (+7.45%) | -3.49M |
Comprehensive Income Net Of Tax | -8.73M (-66.98%) | -26.44M (+19.31%) | -22.16M | - | -25.39M (+21.83%) | -20.84M (+8.20%) | -19.26M (-77.50%) | -85.61M (+292.89%) | -21.79M (+2.20%) | -21.32M (+28.98%) | -16.53M (-79.37%) | -80.11M (+279.85%) | -21.09M (-7.78%) | -22.87M (+15.21%) | -19.85M (-72.17%) | -71.33M (+1287.74%) | -5.14M (-86.17%) | -37.17M (+574.59%) | -5.51M (+70.06%) | -3.24M |